Cargando…
Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
Autores principales: | Kuenzig, M Ellen, Widdifield, Jessica, Bernatsky, Sasha, Kaplan, Gilaad G, Benchimol, Eric I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863433/ https://www.ncbi.nlm.nih.gov/pubmed/35216658 http://dx.doi.org/10.1016/S2468-1253(22)00054-1 |
Ejemplares similares
-
Variation in care of patients with elderly-onset inflammatory bowel
disease in Ontario, Canada: A population-based cohort study
por: Kuenzig, M Ellen, et al.
Publicado: (2020) -
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
por: Widdifield, Jessica, et al.
Publicado: (2022) -
Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada
por: Dheri, Aman K, et al.
Publicado: (2021) -
Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases
por: Khan, Rabia, et al.
Publicado: (2023) -
Costs of missed work among employed people with inflammatory bowel disease: a cross-sectional population-representative study.
por: Kuenzig, Ellen, et al.
Publicado: (2022)